High IDO1 expressing NSCLC displayed elevated expression of proteins mapping to interferon alpha- and gamma-responses, allograft rejection and IL6 STAT3 signaling during acute phase response. The gene discussed is IL6; the disease is non-small cell lung carcinoma.